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Abstract
Background: Unresolved inflammation resulting in capillary leakage with endothelial barrier dysfunction is a
major contributor to postoperative morbidity and mortality after coronary artery bypass graft (CABG). Angiopoietins
(ANGs) are vascular growth factors, also mediating inflammation and disruption of the endothelium, thus inducing
capillary leakage. We hypothesized that changes in the relative serum levels of ANG1 and ANG2 influence
endothelial barrier function and perioperative morbidity after CABG.
Methods: After approval and informed consent, serum samples (n = 28) were collected pre CABG surgery, 1, 6, and
24 h after aortic de-clamping. ANG1, ANG2, soluble ANG receptor TIE2 (sTIE2), and IL-6 serum concentrations were
analyzed by ELISA. Human pulmonary microvascular endothelial cells (HPMECs) were incubated with patient serum
and FITC-dextran permeability was assessed. Furthermore, ANG2 secretion of HPMECs was analyzed after incubation
with IL-6-containing patient serum.
Results: CABG induced an early and sustained increase of ANG2/ANG1 ratio (5-fold after 24 h compared to pre-surgery).
These changes correlated with elevated serum lactate levels, fluid balance, as well as the duration of mechanical
ventilation. Permeability of HPMECs significantly increased after incubation with post-surgery serum showing a marked
shift of ANG2/ANG1 balance (18-fold) compared to serum with a less pronounced increase (6-fold). Furthermore, CABG
resulted in increased IL-6 serum content. Pre-incubation with serum containing high levels of IL-6 amplified the ANG2
secretion by HPMECs; however, this was not influenced by blocking IL-6.
Conclusions: CABG affects the balance between ANG1 and ANG2 towards a dominance of the barrier-disruptive ANG2.
Our data suggest that this ANG2/ANG1 imbalance contributes to an increased postoperative endothelial permeability,
likewise being reflected by the clinical course. The results strongly suggest a biological effect of altered angiopoietin
balance during cardiac surgery on endothelial permeability.
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Background
Coronary artery disease (CAD) is a significant health
threat with increasing prevalence and enormous socio-
economic consequences, and is the leading cause of
morbidity and mortality in the western world [1]. In
addition to percutaneous coronary intervention, coron-
ary artery bypass graft (CABG) surgery remains the gold
standard therapy, especially in patients suffering from
diffuse coronary stenosis [2].
During CABG, global perfusion is routinely main-
tained by establishing a cardiopulmonary bypass (CPB),
usually by means of a heart-lung machine (HLM), so-
called on-pump surgery. In addition to the surgical
trauma, perioperative myocardial injury, and global is-
chemia reperfusion injury, on-pump surgery commonly
results in systemic inflammatory response syndrome
(SIRS) [3]. Development of SIRS influences the postopera-
tive morbidity and mortality and therefore contributes to
prolonged ICU treatment after CABG [4, 5]. One
fundamental characteristic of SIRS is the develop-
ment of endothelial barrier dysfunction [6]. Activation of
the endothelium induces myosin-mediated contractions of
endothelial cells (ECs), leading to the formation of intercel-
lular gaps and subsequent extravasation of fluids, resulting
in hypovolemia, edema, and organ dysfunction such as
acute renal failure, acute respiratory distress syndrome
(ARDS), and cerebral edema [7–10].
Vascular endothelial growth factor (VEGF), initially
termed vascular permeability factor, is linked to the devel-
opment of endothelial barrier dysfunction after CABG
[11]. Angiopoietins (ANGs) represent another prominent
vascular growth factor system. Besides their importance
for the development and maturation of the vasculature,
ANGs mediate activation, inflammation, and disruption of
the endothelium [12–16]. ANG1, continuously secreted
by perivascular mural cells, exerts stabilizing and anti-
apoptotic effects on the endothelium by specific binding
to the TIE2 receptor (Fig. 1) [17, 18]. This ensures endo-
thelial integrity and prevents hyper-permeability and the
trans-endothelial passage of inflammatory cells [12, 19].
In contrast, ANG2 is stored preformed in intracellular
vesicles of the EC, the Weibel-Palade bodies (WPB)
[20]. Distinct stimuli (hypoxia, trauma, endogenous
substances such as thrombin or histamine) trigger its
rapid exocytosis [20–22]. Following secretion, ANG2
competes with ANG1 for binding to the TIE2 receptor,
mediating opposite effects: disruption, hyper-permeability,
and pro-inflammation. ANG2 was identified as a serum
marker of endothelial barrier dysfunction, and a shift in
the relative balance between ANG2 and ANG1 unequivo-
cally contributes to the collapse of the endothelial barrier
in vitro and in vivo [13, 23–25].
We hypothesized that CABG induces substantial alter-
ations in ANG1 and ANG2 serum levels and that these




This observational study was conducted at the cardiac-
surgery suite and ICU at the University Medical Center
Bonn, Germany, in accordance with the Declaration of
Helsinki and after approval by the institutional revenue
board (IRB) at the Rheinische Friedrich-Wilhelms-
Fig. 1 Angiopoietin signaling at the TIE2 receptor. Angiopoietin 1 (ANG1) is constitutively secreted by perivascular mural cells. Ligand-binding of
(ANG1) to TIE2 induces sequestration of the tyrosine kinase Src and thus establishes stable expression of VE-cadherin on the surface of the
endothelial cell. ANG2 is stored in Weibel-Palade (WBP) bodies and rapidly released upon triggering signals. Its binding to TIE2 abolishes ANG1-
induced sequestration of Src, resulting in the internalization of VE-cadherin. Furthermore, sensitizing endothelial cells (EC) for ligands targeting
nuclear factor-κB (NF- κB), such as vascular endothelial growth factor or tumor necrosis factor-α, results in the expression of adhesion molecules
(selectines, intercellular adhesion molecule-1 (ICAM), vascular cell adhesion molecule-1 (VCAM)), which facilitates leukocyte adhesion
and transmigration
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University Bonn (protocol number 011/13). Inclusion cri-
teria were age >18 years of age, elective on-pump CABG
surgery, and written informed consent. The following
patients were excluded from the study: those with
simultaneous valve replacement, emergency procedures
(including acute myocardial infarction within 48 h prior
to surgery), previous major surgery during the last
2 weeks, pre-existing infection, malignancy, pre-
existing renal dysfunction, or pregnancy.
After invasive blood pressure assessment was estab-
lished, anesthesia was induced by intravenous (i.v.)
administration of etomidate, sufentanil, and rocuro-
nium and was further maintained using isoflurane
and continuous sufentanil infusion. Corticoids were
not given to any of the enrolled patients during the
observation period. After intubation and insertion of
a central venous line, median sternotomy was per-
formed in apnea. Before starting the CPB, a heparin
bolus (500 IU/kg body weight) was administered to
obtain an activated clotting time >400 s. After cannu-
lation of the ascending aorta and the right atrium,
CPB was established using a roller pump for non-
pulsatile flow (Advanced Perfusion System 1, Terumo
Corporation, Tokyo, Japan) and a membrane oxygen-
ator (Quadrox-I Adult, Maquet Getinge Group, Ras-
tatt, Germany). The HLM system was primed with
1200 ml of crystalloid infusion solution (Jonosteril,
Fresenius Kabi, Bad Homburg vor der Höhe,
Germany). After full HLM support was installed, car-
diac arrest was induced by administration of Calafiore
warm blood cardioplegia and maintained by repetitive
re-infusion into the aortic root in 20-minute intervals.
The aorta was then cross-clamped. Mild hypothermia
was introduced (34 °C). The left or right internal mam-
mary artery (LIMA, RIMA) and the saphenous vein of ei-
ther leg was used as graft. Upon finishing the distal
anastomosis of all bypass grafts, the patients were re-
warmed to 36.5 °C and, after de-clamping of the aorta and
re-installing normal antegrade perfusion, were weaned
from HLM. Thereafter, heparin was antagonized using
protamine in an equal dose to that of heparin. All patients
were transferred to the ICU for postoperative care and
therapy.
Collection of blood samples and clinical data
Blood (10 ml) of was drawn before the beginning of sur-
gery (preop) and 1, 6, and 24 h after aortic de-clamping.
Samples were immediately centrifuged (3,000 rpm, 4 °C,
10 minutes), and serum aliquots were stored at −80 °C
for subsequent analysis.
The following clinical data were recorded during the
perioperative period:
– duration of surgery (incision - suture) and CPB
– aortic cross-clamp and reperfusion times
– fluid balance (calculated once per hour)
– duration of mechanical ventilation (begins with
intubation after initial induction of general
anesthesia and ends with first extubation on ICU)
– length of stay (LOS) in the ICU
– LOS in the hospital
All data were collected during an observation period
of up to 60 h after admission to the ICU. Clinical labora-
tory parameters were assessed on each patient at ICU
admission and every 6–12 h during ICU treatment.
Detection of ANG1, ANG2, soluble TIE2, and
pro-inflammatory cytokines
Detection of ANG1, ANG2, and soluble TIE2 (sTIE2) levels
in serum samples was performed using enzyme-linked
immunosorbent assay (ELISA) (R&D systems, Wiesbaden-
Nordenstadt, Germany) according to the manufacturer’s
protocol. The ratio between ANG2 and ANG1 (ANG2/
ANG1 balance) was calculated using the formula:
ANG2/ANG1 ratio = ANG2 (ng/ml)/ANG1 (ng/ml).
TNF-α, interleukin (IL)-1β, and IL-6 levels were deter-
mined using ELISA (BD Biosciences, San Jose, CA,
USA) and expressed as pg/ml serum. All experimental
analyses were performed in triplicates. Out of these re-
sults, the mean value was calculated and used for further
statistical analyses. Serum samples obtained early (1 h)
after aortic de-clamping were compared to clinical pa-
rameters describing potentially harmful influences of
surgery and CPB, to detect possible causal relationships
with changing angiopoietin and cytokine levels. To
evaluate a potential influence of changing angiopoietin
levels on the further clinical course, we compared clin-
ical outcome data with serum samples obtained during
the further postoperative ICU stay (6 and 24 h after
CABG).
Cell culture
Cryopreserved pooled human pulmonary microvascular
endothelial cells (HPMECs) and the recommended
ECGM-MV (endothelial cell basal medium (EBM-MV))
with cell-specific supplement) were purchased from Pro-
moCell (Heidelberg, Germany). Cells of less than 6 pas-
sages were cultured in medium until 80–90 %
confluence. For sub-cultivation, cells were washed, har-
vested using Accutase™ solution (Sigma-Aldrich, Tauf-
kirchen, Germany), and seeded in ECGM-MV into the
corresponding cell culture plastics depending on the in-
dividual corresponding assay. Cells were cultured at 37 °
C in a 5 % CO2 humidified atmosphere. All culture plas-
tics were coated with 0.2 % gelatin in phosphate-
buffered saline (PBS) before use.
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Assessment of endothelial permeability
Transwell™ permeable supports (0.33-cm2, 0.4-μm pore
size, polycarbonate membrane; Corning, Tewksbury, MA,
USA) were coated with gelatin and equilibrated with
medium. Subsequently, HPMECs in ECGM-MV were
seeded into the upper compartment in high density and
cultured to form a confluent monolayer. Culture medium
was changed every other day and particular attention was
paid not to abolish the cell layer integrity.
After 3 days, supernatant was replaced by fresh culture
medium supplemented with sterile (0.2 μm)-filtered preop
or 24-h serum, respectively. Based on previous dose
titrations a 7.5 % serum supplement was the optimal concen-
tration for these experiments. Control cells were supple-
mented with 7.5 % fetal calf serum (FCS). After 30-minute
incubation, fluorescein isothiocyanate (FITC)-conjugated
dextran (70 kiloDalton (kDa), final concentration 1 mg/ml;
Sigma-Aldrich, St. Louis, MO, USA) was added to the
upper compartment and the inserts were transferred into
pre-warmed assay buffer (4-(2-hydroxyethyl)-1-piperazi-
neethanesulfonic acid (HEPES)-buffered Hank’s balanced
salt solution (HBSS), pH 7.4) on a magnetic stirrer
(400 rpm). After an initial equilibration period of
15 minutes, thrombin (final concentration 1 IU/ml;
Sigma-Aldrich, St. Louis, MO, USA) was added to the
upper compartment to induce endothelial permeability.
Control cells were treated with assay buffer. A 50-μl
sample was taken from the lower compartment after 5,
10, 15, 30, and 60 minutes and was replaced by an equiva-
lent volume of fresh assay buffer. Fluorescence was mea-
sured using a fluorescent plate reader (excitation 492 nm,
emission 518 nm; Modulus II Microplate Multimode
Reader, Promega, Fitchburg, WI, USA). Concentration of
dextran was calculated using an experimentally derived
standard curve and the flux over the membrane was cal-
culated. Thrombin-induced hyper-permeability was
expressed as times fold of the average basal flux dur-
ing the initial 15-minute equilibration period before
thrombin addition.
Determination of ANG2 secretion by HPMECs
HPMECs were seeded into 96-well flat-bottom plates
and cultured in ECGM-MV. At 80–90 % confluence, the
supernatant was replaced by fresh culture medium sup-
plemented with sterile (0.2 μm-)filtered preop or 1-h
serum, respectively. Based on previous dose-response ti-
trations a 5 % serum supplement was the optimal con-
centration for these experiments. Control cells were
supplemented with 5 % FCS. In additional experiments,
cells were incubated with an inhibiting anti-human-IL-6
antibody (1 μg/ml; BioLegend, San Diego, CA, USA).
After 24 h incubation, the supernatant was discarded
and 55 μl of fresh EBM-MV was added. WPB exocytosis
and thus, ANG2 secretion was triggered by adding
thrombin (1 IU/ml) to the wells. After 1 h the super-
natant was collected and ANG2 concentration was de-
termined by ELISA (R&D systems, Wiesbaden-
Nordenstadt, Germany).
Statistics
Statistical analysis and visualization of data was performed
using GraphPad PRISM 5 (La Jolla, CA, USA). Unless
otherwise stated, graphs represent median with percentile
25–75 (Q1–Q3). Values lying outside ± 2.5 times the me-
dian absolute deviation around the median were identified
as outliers and thus excluded (according to the method
presented by Leys et al.) [26]. The significance of time-
dependent changes in serum data was tested using Krus-
kal–Wallis one-way analysis of variance followed by
Dunn’s post-hoc test. Results of the in vitro experiments
are presented as mean ± standard error of the mean
(SEM), and the two-tailed (or one-tailed, if appropriate),
unpaired Student’s t test was used to compare the differ-
ent groups. Pearson’s correlation test was used to analyze
association between serum data and clinicopathologic var-




A total of 28 consecutive patients were included in the study.
Two patients were discharged from ICU before the end of
the 24-h period after aortic de-clamping, and sample acquisi-
tion was not continued on the peripheral ward, resulting in
missing samples for the 24-h time point (T24) for these two
patients. Eighty-six percent were male and the median age
was 72 years with a range from 55 to 83 years. The median
body mass index (BMI) was 26.8 kg/m2. The median CPB
time was 110 minutes, the median aortic cross-clamp time
was 68 minutes, and the median time for reperfusion was
33 minutes. The median total procedure time (cutting to su-
ture) was 279 minutes. The median ICU LOS was 23.9 h
and the median hospital LOS was 14 days. No patient
showed clinical signs of wound infection, required repeat
surgery or died within 30 days post surgery (Table 1).
CABG impairs angiopoietin balance
CABG induced an immediate and persistent decrease in
ANG1 and increase in ANG2 serum levels. Median ANG1
levels significantly decreased 1 h after aortic de-clamping
compared to pre-surgical concentrations (10.5 vs. 14.3 ng/
ml, p <0.01), and the decrease was sustained for 24 h
(12.2 ng/ml; Fig. 2a). In contrast, circulating ANG2 levels in-
creased significantly 1 h after aortic de-clamping compared
to pre-surgical concentrations (1.04 vs. 0.54 ng/ml ng/ml, p
<0.001), and the increase was sustained during the 24-h ob-
servational period (1.86 ng/ml; Fig. 2b). The ratio between
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ANG2 and ANG1 at baseline was 0.04. This ratio signifi-
cantly increased to 0.1 after 1 h and continued up to 0.18 at
24 h after CABG (p <0.001), indicating a robust five-fold in-
crease 24 h after aortic de-clamping (Fig. 2c).
The soluble form of the TIE2 receptor (sTIE2) was de-
tectable in the serum (baseline level 3.61 ng/ml); how-
ever, CABG had no effect on sTIE2 serum concentrations
(Fig. 2d).
Table 1 Basic patient characteristics, intraoperative and postoperative details
Characteristics
Male sex Number (percentage) 24 (86)
Age, years Median (range) 72 (55–83)
Body mass index, kg BW/m2 Median (range) 26.8 (19.6–37.2)
Cardiovascular status, kidney
Ejection fraction, % Median (range) 55 (22–85)
NYHA status Median (range) 2 (1–3)
Arterial hypertension Number (percentage) 28 (100)
Carotid stenosis Number (percentage) 8 (29)
PAOD Number (percentage) 1 (4)
Serum creatinine, mg/dl Median (Q1–Q3) 1 (0.85–1.1)
Details of procedure
Cutting-suture time, minutes Median (Q1–Q3) 279 (233–291)
CPB time, minutes Median (Q1–Q3) 110 (98–124)
Aortic cross-clamp/reperfusion time, minutes Median (Q1–Q3) 105 (92–116)
Cardioplegic solution, ml Median (Q1–Q3) 710 (700–732)
Number of grafts Median (range) 4 (1–4)
Number of intraoperative. transfused RBC concentrates Median (range) 0 (0–4)
Postoperative details
PaO2/FiO2 ratio at admission to ICU Median (Q1–Q3) 244 (195–326)
PaO2/FiO2 ratio after 6 h Median (Q1–Q3) 333 (251–383)
PaO2/FiO2 ratio after 24 h Median (Q1–Q3) 419 (295–497)
Lactate at admission to ICU, mmol/l Median (Q1 −Q3) 1.1 (0.9–1.74)
Lactate after 6 h, mmol/l Median (Q1–Q3) 1.28 (1.07–1.71)
Lactate after 24 h, mmol/l Median (Q1–Q3) 1.3 (1.07–1.43)
Norepinephrine at admission to ICU, μg/kg BW*minute Median (Q1–Q3) 0.03 (0–0.09)
Norepinephrine after 6 h, μg/kg BW*minute Median (Q1 - Q3) 0.03 (0 − 0.06)
Norepinephrine after 24 h, μg/kg BW*minute Median (Q1–Q3) 0 (0–0)
Hgb at admission to ICU, mmol/l Median (Q1–Q3) 11.2 (10.8–12.7)
Hgb after 6 h, mmol/l Median (Q1–Q3) 10.7 (10–11.5)
Hgb after 24 h, mmol/l Median (Q1–Q3) 9.8 (9.3–10.5)
24 h crystalloid fluid balance, ml Median (Q1–Q3) 3310 (2635–4860)
Serum creatinine at admission to ICU, mg/dl Median (Q1–Q3) 0.85 (0.77–1.01)
Serum creatinine after 24 h, mg/dl Median (Q1–Q3) 1 (0.85–1.12)
Duration of mechanical ventilation, h Median (Q1–Q3) 17.75 (14.25–19.8)
Length of stay on ICU, h Median (Q1–Q3) 23.9 (21.3–69.6)
Length of stay in hospital, d Median (Q1–Q3) 14 (9–17)
CPR Number (percentage) 0 (0)
Revision surgery Number (percentage) 0 (0)
NYHA New York Heart Association classification, PAOD peripheral arterial occlusive disease, CPB cardiopulmonary bypass, RBC red blood cell, PaO2 arterial oxygen
partial pressure, FiO2 inspiratory oxygen fraction, ICU intensive care unit, Hgb hemoglobin, CPR cardiopulmonary resuscitation, Q1–Q3 percentile 25–75
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Clinical parameters correlate with changes in ANG2/ANG1
ratio
Correlation analysis revealed an association between an
increased ANG2/ANG1 ratio and several clinical param-
eters. The ANG2/ANG1 ratio at 1 h after aortic de-
clamping was positively correlated with the duration of
ischemia and reperfusion (r = 0.5, p <0.05) and the dos-
age of administered vasopressive agents (r = 0.5, p
<0.01; Fig. 3a). Furthermore, serum lactate as a surro-
gate marker for impaired tissue oxygenation was likewise
positively associated with early angiopoietin imbalance (r
= 0.6, p <0.005). Of note, positive correlations with in-
creased serum lactate levels remained detectable up to
24 h after CABG (r = 0.7, p <0.005).
An increased ANG2/ANG1 ratio 24 h after CABG
correlated with a positive balance of crystalloid infu-
sion fluids (r = 0.6, p <0.005; Fig. 3b). Patients with
ANG2/ANG1 values above the median had signifi-
cantly greater fluid intake than those with ratios
below the median and a trend towards longer ICU LOS
(Table 2). Moreover, an increase in the angiopoietin ratio
after 6 h and after 24 h, was associated with the duration
of mechanical ventilation, possibly reflecting vascular
leakage-related impaired pulmonary performance (r = 0.5,
p <0.05; Fig. 3b).
The associations were more modest or even unverifi-
able when testing correlation independently with ANG1
or ANG2.
An increased ANG2/ANG1 ratio facilitates endothelial
hyper-permeability ex vivo
Thrombin induced rapid transendothelial dextran flux
within 10 to 15 minutes (Fig. 4). Thereafter, with reseal-
ing of ECs, the transmembrane flux decreased, reaching
Fig. 2 Changes in angiopoietin and TIE2 serum levels upon coronary artery bypass graft (CABG). Serum was sampled from patients being scheduled
for elective on-pump CABG before surgery (preop) and 1, 6 and 24 h after closure of the aortic clamp. Serum was analyzed for angiopoietin 1 (ANG1)
(a), ANG2 (b) and soluble TIE2 receptor (sTIE2) (d) by enzyme-linked immunosorbent assay. Furthermore, the ANG2/ANG1 ratio was calculated (c).
N = 28 (24-h time point, n = 26), median with percentile 25–75, *p <0.05, **p <0.01, ***p <0.001 (vs. preop). CPB cardiopulmonary bypass
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baseline levels after approximately 60 minutes. Pre-
incubation of ECs with serum samples containing a mild
shift in angiopoietins upon CABG (increase of ANG2/
ANG1 ratio 6-fold from baseline to 24 h) had no signifi-
cant effect on thrombin-induced permeability compared
to the use of preop serum. However, serum samples with
a pronounced ANG2/ANG1 imbalance upon CABG (in-
crease of ANG2/ANG1 ratio 18-fold from baseline to
24 h) provoked a significant hyper-permeability of the
endothelial monolayer upon thrombin addition in com-
parison to preop samples. This effect was maintained
over at least 60 minutes.
CABG increases IL-6 levels
SIRS after CABG is characterized as a systemic pro-
inflammatory reaction accompanied by endothelial bar-
rier dysfunction and vasoplegia. Pre-surgical IL-6 levels
were low (3.0 pg/ml, Fig. 5a); however, upon CABG, IL-
6 concentrations significantly increased 1 h after aortic
de-clamping and were even further increased after 6 h
(435 pg/ml, p <0.001). At 24 h after aortic de-clamping,
IL-6 levels remained significantly elevated compared to
pre-surgical levels (144 pg/ml, p <0.001). Neither TNF-α
nor IL-1β was detectable in the serum before or after
CABG (data not shown).
Pro-inflammatory conditioned serum, but not IL-6,
increases ANG2 release ex vivo
The early increase in IL-6 serum concentrations 1 h
after de-clamping was associated with increasing
ANG2 levels measured 24 h after de-clamping (r =
0.7, p <0.001; Fig. 5a). The ANG2/ANG1 imbalance
upon CABG is mainly driven by increasing serum
ANG2 levels (Fig. 2a). To test the hypothesis that IL-
6 is a humoral factor enhancing the release of ANG2
from WPBs, HPMECs were incubated with patient
serum (preop or 1 h, respectively) with and without
addition of an inhibiting anti-human-IL-6 antibody,
Fig. 3 Correlation between the angiopoietin (ANG)2/ANG1 ratio and clinical parameters. Pearson’s correlation was calculated to test the
association between altered ANG2/ANG1 balance and clinical parameters. a Correlation between early ANG imbalances (1 h after coronary artery
bypass graft (CABG)) and dosage of norepinephrine administered after CABG (left), and serum lactate levels measured at admission to the ICU
(right). b Correlation between late increase of ANG balance (24 h after CABG) and crystalloid fluid balance 24 h after admission to ICU (left), and
duration of mechanical ventilation (right). BW body weight
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followed by the detection of released ANG2 in the
supernatant. Pre-incubation with either preop or with
1-h serum had no significant effect on ANG2 secre-
tion when the IL-6 content of the sample was low
(on average 78 pg/ml in the 1-h serum; Fig. 5b). In
contrast, pre-incubation with 1-h serum samples with
nearly 10 times higher IL-6 contents (739 pg/ml) in-
duced a significant amplification of ANG2 activity in
the cell supernatant compared to incubation with
preop serum from the same patients. Addition of an
inhibiting anti-IL-6 antibody did not abolish this
effect.
Table 2 Influence of the 24-h ANG2/ANG1 ratio
Variable ANG2/ANG1 ANG2/ANG1 p value
<0.18 >0.18
Details of patients and procedure
Preoperative ejection fraction, % 60 (53–67) 50 (44–55) 0.01
CPB time, minutes 113 (90–125) 110 (103–125) 0.49
Aortic cross-clamp/reperfusion time, minutes 105 (85–120) 105 (93–115) 0.9
Postoperative details (T24)
PaO2/FiO2 ratio 407 (360–502) 429 (182–481) 0.79
Lactate, mmol/l 1.27 (1–1.4) 1.32 (1.1–1.2) 0.68
Hgb, mmol/l 9.7 (9.3–10.4) 10.2 (9.1–11.6) 0.52
Crystalloid fluid balance, ml 3100 (2340–3735) 4830 (3310–5720) 0.01
Serum creatinine, mg/dl 1.03 (0.9–1.12) 0.98 (0.74–1.19) 0.58
Duration of mechanical ventilation, h 16.5 (10.3–18.9) 18.8 (17.1–20.2) 0.12
ICU LOS, h 22.2 (21–35.4) 44.4 (21.3–74.6) 0.2
LOS hospital, days 14 (9–15) 14 (11–21) 0.12
The study population was divided into two groups according to the angiopoietin (ANG)2/ANG1 ratio measured 24 h after aortic de-clamping using the overall
median ratio (0.18) as threshold value. Details are presented for patients, procedures, and postoperative variables recorded 24 h after admission to ICU (T24).
Median with percentile 25–75, two-tailed Mann–Whitney test. CPB cardiopulmonary bypass, PaO2 arterial oxygen partial pressure, FiO2 inspiratory oxygen fraction,
Hgb hemoglobin, ICU LOS length of stay on intensive care unit, LOS hospital length of stay in hospital
Fig. 4 Influence of angiopoietin (ANG)2/ANG1 imbalance on endothelial hyper-permeability ex vivo. Human pulmonary microvascular endothelial
cells were seeded at high density on gelatin-coated permeable supports and cultured to form a confluent monolayer. After pre-incubation with
filtered and diluted (7.5 %) patient serum (preoperative (preop) or 24 h, respectively) for 30 minutes, fluorescein isothiocyanate (FITC)-conjugated
dextran (70 kDa, final concentration 1 mg/ml) was added to the upper compartment and the inserts were set on a magnetic stirrer. Thrombin
(final concentration 1 IU/ml) was added to induce endothelial permeability. Samples (of 50 μl) were taken from the lower compartment at the
indicated time points. Dextran concentration was determined using a fluorescent plate reader. Thrombin-induced hyper-permeability is expressed
as fold of the average basal flux during the initial 15-minute equilibration period before thrombin addition. Left, change in endothelial cell (EC)
permeability after pre-incubation with serum samples with a mild shift in the ANG2/ANG1 ratio upon coronary artery bypass graft (CABG) (6-fold
from baseline to 24 h). Right, change of EC permeability after pre-incubation with serum samples with pronounced shift in the ANG2/ANG1 ratio
upon CABG (18-fold from baseline to 24 h). N = 8–10, mean ± standard error of the mean, *p <0.05, **p <0.01. Pat patient
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Discussion
The objective of this study was to assess the impact of
CAGB surgery-induced alterations in ANG1, ANG2 and
TIE2 levels on post-surgical SIRS and to evaluate poten-
tial mechanisms inducing capillary leakage. Our results
indicate that CABG induced profound changes in the
ANG2/ANG1 balance with loss of the barrier-protective
ANG1 and an increase in the barrier-disruptive ANG2
contents in the patients’ serum. This imbalance was
observed in adult patients with systemic pro-
inflammatory response characterized by elevated IL-6
levels. The molecular changes correlated with clinical
surrogate parameters of an impaired endothelial barrier
function, such as fluid balance, application of vasocon-
strictors, and prolonged ventilation.
In healthy individuals, constitutive expression of
ANG1 results in much higher serum concentrations
than ANG2, which is mainly secreted upon endothelial
Fig. 5 Association between interleukin (IL)-6 serum activity and angiopoietin (ANG)2 levels. a Serum was sampled from patients being scheduled
for elective on-pump coronary artery bypass graft (CABG) before surgery (preop) and 1, 6 and 24 h after closure of the aortic clamp. Serum was
analyzed for IL-6 (enzyme-linked immunosorbent assay (ELISA)) (left). The early increase in IL-6 1 h after CABG correlates with further increasing
ANG2 levels measured 24 h after de-clamping (right): n = 28 (24 h time point, n = 26), median with percentile 25–75, ***p <0.001 (vs. preop). b Human
pulmonary microvascular endothelial cells were cultured in 96-well plates and pre-incubated with filtered and diluted (5 %) patient serum (preop
(clear bars) or 1 h (hatched bars), respectively) and anti-human-IL-6 antibody (1 μg/ml) for 24 h. Supernatant was discarded, and triggered
ANG2 secretion was induced by adding thrombin (1 IU/ml) in fresh culture medium. After 1 h, the ANG2 concentration was determined by ELISA.
Fold change of triggered ANG2 secretion (compared to basal secretion without thrombin addition) is shown after pre-incubation with serum with low
IL-6 activity (white bars) vs. serum with high IL-6 concentration (gray bars). The bar on the right shows ANG2 secretion when ‘high IL-6 1 h’ serum
pre-incubation was combined with anti-human-IL-6 antibody: n = 6–9, mean ± standard error of the mean, *p <0.05. CPB cardiopulmonary bypass
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stimulation; therefore, an increased ratio between ANG2
and ANG1 (in healthy adults a numerical value below 1)
serves as marker of endothelial activation [23]. Various
cardiovascular diseases including atherosclerosis, CAD,
and acute myocardial infarction (MI) affect the expres-
sion of angiopoietins [27, 28]. Upon clinical manifest-
ation of these conditions, serum levels of ANG2 increase
significantly and its biological effect is to overcome the
basal vascular-stabilizing function of ANG1 [19, 23].
The population in the current study comprised clinically
stable patients being scheduled for elective CABG, thus
basal ANG2/ANG1 ratios were marginally elevated.
ANG2/ANG1 ratios increased early after CABG in our
patients and remained elevated for 24 h. Giuliano et al.
described similar alterations in angiopoietin serum levels
in children undergoing surgery for congenital heart
disease [29]. However, in infants with congenital heart
disease, systemic hypoxia due to veno-arterial shunts
induces significant changes in angiopoietin levels,
which persist into later life, limiting the relevance of these
results to our adult patients [30]. Furthermore, ANG2
response to cardiac surgery may be age-dependent in
general [29].
The observed alterations in the ANG2/ANG1 balance
correlated with several clinical variables. Besides the
surgical trauma, ischemia and reperfusion (I/R) are
among the most harmful events during cardiac surgery,
occurring locally in the heart during cross-clamping and
systemically following the reperfusion period. The
myocardium itself is a major source of CPB-related
inflammation, and extended cross-clamp times are associ-
ated with increased cytokine expression [31, 32]. Beside I/
R-mediated pro-inflammatory responses, I/R also contrib-
utes to alterations in angiopoietin balance, favoring ANG1
downregulation, and increasing ANG2 activity [33].
Accordingly, a shift in the ANG2/ANG1 ratio after CABG
was associated with I/R time in our patients.
The observed correlation beteen an altered ANG2/
ANG1 ratio and the dosage of administered vasopressive
agents offers scope for speculation. On one hand, it has
been shown that loss of the balance between vaso-
protective ANG1 and vaso-destructive ANG2 (e.g., during
sepsis) results in the emergence of endothelial dysfunction
[16]. The latter is described as the lack of constitutive
endothelial NO synthase (eNOS), being outnumbered
by inducible vaso-relaxing factors (such as reactive
oxygen species or inducible NOS (iNOS)) [34]. This
may lead to profound vasoplegia with an increased
need for vasopressive agents [35]. On the other hand,
we noted that disturbances in the angiopoietin balance
were furthermore associated with elevated serum lac-
tate levels throughout the entire observation period.
Lactate is increasingly produced when perfusion is in-
sufficient to meet the oxygen demand of the cell, and
tissue hypo-perfusion, and thus, ischemia contribute
to both lactic acidosis and shifts in the ANG2/ANG1
ratio [33]. Vasopressive agents themselves, such as norepin-
ephrine, provoke tissue hypo-perfusion and thus, increased
lactate production and ANG2 release [36]. Interestingly,
lactate itself stimulates the upregulation of ANG1
and subsequently activates TIE2 signaling, and may
therefore be a compensatory response to counteract
impaired microcirculation [37].
Contact between blood and artificial surfaces may alter
the expression of ANG2 [38]. However, ECs release the
previously synthesized protein from cytoplasmatic vesi-
cles upon a distinct trigger, and it remains unclear what
finally mediates ANG2 release during and after CABG.
In our study, elevated serum ANG2, mainly driving the
shift in the ANG2/ANG1 balance upon CABG, was cor-
related with an early increase in IL-6 serum levels. Re-
sults from clinical studies suggest that pro-inflammatory
mediators may be associated with the regulation of
ANG2 [39, 40]. IL-6 is not known to trigger WPB exo-
cytosis. However, signal transducer and activator of tran-
scription 3 (STAT3) as a key regulator of the IL-6
receptor pathway has been shown to upregulate ANG2
synthesis upon phosphorylation [41]. Thus, our hypoth-
esis was that IL-6 itself upregulates ANG2 synthesis and
induces increased filling of the vesicles, subsequently
leading to enhanced exocytosis. Sera with high IL-6
levels 24 h after CABG significantly increased the
amount of ANG2 in the supernatant of ECs compared
to low-level IL-6 sera. However, blocking experiments
revealed that IL-6 is merely the reflection of a strong
pro-inflammatory response to CABG and does not sig-
nificantly influence the EC independently. The mecha-
nisms leading to increased ANG2 serum activity upon
CABG remain to be further investigated.
Elevated ANG2/ANG1 ratios are related to vascular
leakage [24]. When we treated confluent layers of ECs
with patient sera, we observed a pronounced disruption
of the endothelial barrier for high molecular weight
dextran upon thrombin addition, and this effect was
dependent upon the extent of the ANG2/ANG1 imbal-
ance. Compared to preop sera, 24-h sera with a distinct
shift in the ANG2/ANG1 ratio after CABG provoked sig-
nificant hyper-permeability of endothelial monolayers.
Unfortunately, an inhibiting ANG2 antibody was not
available for us, thus, our study lacks the final causal
proof. However, despite this limitation, there is strong
evidence for the contribution of altered ANG2/ANG1
balance to endothelial barrier dysfunction after CABG,
likewise supported by other authors. Clajus et al. demon-
strated increasing ANG2 serum levels during and after
cardiac surgery [42]. Incubating ECs with these sera in-
duced alterations of the endothelial architecture. As this
effect was abolished by the addition of recombinant
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ANG1, the authors concluded that the observed EC per-
meability was ANG2-mediated. Clinically, in our study,
angiopoietin ratios measured later during the clinical
course were correlated with positive fluid balance as a sur-
rogate marker for endothelial barrier disruption. More-
over, high ANG2/ANG1 levels were associated with
prolonged duration of mechanical ventilation. This is like-
wise in line with reports from other authors describing a
key role of angiopoietins for the development of sepsis-in-
duced vascular leakage and pulmonary dysfunction
[14–16, 25]. Recently, Uchida et al. demonstrated an
association between elevated postoperative ANG2
levels and the development of respiratory failure after
cardiac surgery [43]. However, we can only partially
confirm this, because the ANG2 levels that we measured
after CABG were not correlated with a prolonged
need for mechanical ventilation (in contrast to the
ANG2/ANG1 ratio).
Our study generates hypotheses, but it has limitations.
First, due to a small sample size and strict inclusion and ex-
clusion criteria, it lacks external validity. Second, we in-
cluded neither a healthy control group (to correctly classify
baseline angiopoietin levels) nor patients undergoing sur-
gery using modified CPB or even off-pump CABG surgery.
Thus, the observed effects cannot be exclusively ascribed to
CPB. Recently, Uchida et al. reported significantly altered
angiopoietin serum levels in patients undergoing on-pump
vs. off-pump cardiac surgery [43]. Elevated ANG2 and de-
creased ANG1 levels after percutaneous coronary revascu-
larization suggest that the heart is likewise a major source
of the altered ANG2/ANG1 ratio even after CABG [44].
However, surgical trauma may be another cause of ele-
vated ANG2 levels, as evidenced by studies on patients
after traumatic lung injury or non-cardiac thoracic sur-
gery [45, 46]. Reducing invasiveness by the use of endo-
scopic techniques likewise reduces post-procedural
ANG2 serum levels in those patients, which further-
more supports the hypothesis that CPB during cardiac
surgery may play a subordinate role in influencing the
ANG2/ANG1 balance compared to the surgical trauma
[47]. Our data support this conclusion as well, because
total CPB time did not correlate with altered ANG2/
ANG1 ratio. Third, the cohort we studied consisted of
elective low-risk patients who could be rapidly discharged
from the ICU. In high-risk patients, the postoperative
levels of circulating angiopoietins may be different. Fourth,
endothelial permeability was assessed in vitro using a sin-
gle cell type assay, which is rather artificial. Fluid balance
and duration of mechanical ventilation are only clinical
surrogates for a disturbed endothelial barrier. Methods to
evaluate vascular leakage in vivo, such as measuring extra-
vascular lung water, bioelectrical impedance analysis to
determine the extracellular and total body water, or im-
aging of extravasated radiolabeled macromolecules, would
have been advantageous [48, 49]. Finally, there was a lack
of an inhibiting ANG2 antibody to prove a causal rela-
tionship between increased ANG2/ANG1 balance and
endothelial hyperpermeability.
Conclusions
The results of our study provide evidence that CABG
significantly affects the balance between ANG1 and
ANG2 towards a dominance of the barrier-disruptive
ANG2. Our data suggest that this ANG2/ANG1 imbal-
ance contributes to an increased postoperative endothelial
permeability, which is likewise reflected by the further
clinical course. This study is in line with others describing
dynamic changes in angiopoietins during cardiac surgery,
however, it is the first to strongly suggest a biological ef-
fect on endothelial permeability. The mechanisms leading
to altered angiopoietin activity remain to be investigated
in future studies.
Key messages
 CABG surgery shifts the balance between ANG1
and ANG2 towards a dominance of the barrier-
disruptive ANG2.
 This contributes to surrogate markers of increased
postoperative endothelial permeability
 The increased serum ANG2/ANG1 ratio facilitates
endothelial hyper-permeability ex vivo
 Systemic inflammation after CABG correlates with
increasing serum ANG2 levels
 Pro-inflammatory conditioned patient serum
contributes to enhanced endothelial ANG2 release
ex vivo
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